Testosterone Conversion


*T trial may be considered in individual cases based on total T/symptoms and low calculated free T 2

  1. Wang C et al., Investigation, Treatment, and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, EAU, EAA, and ASA Recommendations, J European Urology (2009), 55, 121-130

Restore the man is organised and funded by Bayer and may contain some promotional content.

Licensed for:
In the UK, Nebido® (testosterone undecanoate) is Licensed for testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

This website is intended for Healthcare Professionals resident in the UK.